AMERICAN VIRTUAL CLOUD TECHN (AVCT)       0.598  -0.07 (-11.01%)

0.598  -0.07 (-11.01%)

US0303822045 - Common Stock - After market: 0.6 +0 (+0.33%)


Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to AVCT. AVCT was compared to 154 industry peers in the IT Services industry. AVCT scores bad on very profitability, while its financial health is fine. Not spectacular, but in line with the averages. AVCT is valued expensive and it does not seem to be growing.

Note: AVCT has only limited data available, so a full analysis was not possible, which makes the total rating unfair.




Profitability

Profitability Rating

1

AVCT has a Piotroski-F score of 4.00. This indicates an average health and profitability for AVCT.

VS Industry

Valuation

Valuation Rating

2

When comparing the price book ratio of AVCT to the average industry price book ratio of 3.04, AVCT is valued rather cheaply.
When comparing the current price to the book value of AVCT, we can conclude it is valued correctly. It is trading at 1.11 times its book value.

The Price/Earnings Ratio is negative for AVCT. In the last year negative earnings were reported.
VS Industry

Price/Book (1.11) VS Industry: 79% outperformed.

126.64
0.04

Growth

Growth Rating

0

AVCT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -126.62%.

The Revenue for AVCT has decreased by -58.64% in the past year. This is quite bad

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPSN/A N/A -126.62% N/A N/A N/A N/A
RevenueN/A N/A -58.64% N/A N/A N/A N/A

Health

Health Rating

5

A Current Ratio of 2.29 indicates that AVCT has no problem at all paying its short term obligations.
When comparing the Current Ratio to an average industry Current Ratio of 1.46, AVCT is better placed than the average industry peer to meet its short term obligations.
AVCT has a Quick Ratio of 2.29. This indicates that AVCT is financially healthy and has no problem in meeting its short term obligations.
The Quick Ratio of AVCT is much better than the industry average of 1.45.

With a Debt to Equity ratio of 0.00, AVCT is one of the better performing companies in its industry. It outperforms 82% of its industry peers.
AVCT has a Piotroski-F score of 4.00. This indicates an average health and profitability for AVCT.
AVCT has an Altman-Z score of -17.50. This is a bad value and indicates that AVCT is not financially healthy and even has some risk of bankruptcy.
When comparing the Altman-Z score of AVCT to the average industry Altman-Z score of 1.93, AVCT is less financially healthy than its industry peers. 98% of its industry peers have a better Altman-Z score.
VS Industry

Debt/Equity (0) VS Industry: 82% outperformed.

48.59
0.00

Quick Ratio (2.29) VS Industry: 77% outperformed.

0.04
11.05

Current Ratio (2.29) VS Industry: 77% outperformed.

0.04
11.05

Altman-Z (-17.5) VS Industry: 2% outperformed.

-270.29
25.90

Dividend

Dividend Rating

0

AVCT does not give a dividend.

AMERICAN VIRTUAL CLOUD TECHN0.598

NASDAQ:AVCT (1/19/2023, 7:09:50 PM)-0.07 (-11.01%)

After market: 0.6 +0 (+0.33%)

Chartmill FA Rating
GICS Sector Information Technology
GICS IndustryGroup Software & Services
GICS Industry IT Services
Earnings (Last) 11-25 2022-11-25/amc Earnings (Next) N/A N/A
Inst Owners 118.18% Inst Owner Change -0.03%
Ins Owners 3.8% Ins Owner Change 0%
Market Cap 19.42M Analysts 82.86
Price Target 7.14 (1093.98%)

Dividend
Dividend Yield N/A Dividend Growth N/A
DP N/A Ex-Date N/A

Surprises & Revisions
EPS beat(2) N/A Avg EPS beat(2) N/A
Min EPS beat(2) N/A Max EPS beat(2) N/A
EPS beat(4) N/A Avg EPS beat(4) N/A
Min EPS beat(4) N/A Max EPS beat(4) N/A
Revenue beat(2) N/A Avg Revenue beat(2) N/A
Min Revenue beat(2) N/A Max Revenue beat(2) N/A
Revenue beat(4) N/A Avg Revenue beat(4) N/A
Min Revenue beat(4) N/A Max Revenue beat(4) N/A
PT rev (1m) 0% EPS NQ rev (1m) N/A
EPS NY rev (1m) N/A Revenue NQ rev (1m) N/A
Revenue NY rev (1m) N/A

Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.6
P/FCF N/A
P/OCF N/A
P/B 1.11
P/tB 1.11
EV/EBITDA N/A
EPS(TTM) -72.14 EY N/A
EPS(NY) N/A Fwd EY N/A
FCF(TTM) -2.27 FCFY N/A
OCF(TTM) -2.23 OCFY N/A
SpS 1 BVpS 0.54
TBVpS 0.54 PEG (NY) N/A
PEG (5Y) N/A

Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM N/A
GM 5.46%
ROICexgc(3y) N/A ROICexcg growth 3Y N/A
ROICexcg growth 5Y N/A ROICexc(3y) N/A
ROICexc growth 3Y N/A ROICexc growth 5Y N/A
OM growth 3Y N/A OM growth 5Y N/A
PM growth 3Y N/A PM growth 5Y N/A
GM growth 3Y N/A GM growth 5Y N/A
F-Score 4 Asset Turnover 1.05

Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 57.88%
Profit Quality N/A
Current Ratio 2.29
Quick Ratio 2.29
Altman-Z -17.5
F-Score 4 WACC 10.11%
ROIC/WACC N/A Cap/Depr(3y) N/A
Cap/Depr(5y) N/A Profit Quality(3y) N/A
Profit Quality(5y) N/A

Growth
EPS 1Y -126.62% EPS 3Y N/A
EPS 5Y N/A EPS growth Q2Q 87.4%
EPS Next Y N/A EPS Next 2Y N/A
EPS Next 3Y N/A EPS Next 5Y N/A
Revenue growth 1Y -58.64% Revenue growth 3Y N/A
Revenue growth 5Y N/A Revenue growth Q2Q 14.22%
Revenue Next Year N/A Revenue Next 2Y N/A
Revenue Next 3Y N/A Revenue Next 5Y N/A
EBIT growth 1Y -71.84% EBIT growth 3Y N/A
EBIT growth 5Y N/A EBIT Next Year N/A
EBIT Next 3Y N/A EBIT Next 5Y N/A
FCF growth 1Y -427.9% FCF growth 3Y N/A
FCF growth 5Y N/A OCF growth 1Y -432.2%
OCF growth 3Y N/A OCF growth 5Y N/A

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA